Oscar Health, Inc. $OSCR Shares Sold by Deutsche Bank AG

Deutsche Bank AG trimmed its holdings in Oscar Health, Inc. (NYSE:OSCR) by 9.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 155,795 shares of the company’s stock after selling 16,332 shares during the quarter. Deutsche Bank AG owned approximately 0.06% of Oscar Health worth $2,042,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of OSCR. Larson Financial Group LLC grew its position in Oscar Health by 83,733.3% during the 1st quarter. Larson Financial Group LLC now owns 2,515 shares of the company’s stock worth $33,000 after purchasing an additional 2,512 shares during the last quarter. CWM LLC raised its holdings in shares of Oscar Health by 50.7% in the first quarter. CWM LLC now owns 3,204 shares of the company’s stock valued at $42,000 after buying an additional 1,078 shares during the last quarter. Princeton Global Asset Management LLC acquired a new stake in shares of Oscar Health during the first quarter worth about $59,000. GAMMA Investing LLC grew its holdings in shares of Oscar Health by 2,156.4% during the first quarter. GAMMA Investing LLC now owns 6,476 shares of the company’s stock worth $85,000 after buying an additional 6,189 shares during the last quarter. Finally, Tower Research Capital LLC TRC grew its holdings in shares of Oscar Health by 171.4% during the fourth quarter. Tower Research Capital LLC TRC now owns 6,627 shares of the company’s stock worth $89,000 after buying an additional 4,185 shares during the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have commented on OSCR. Robert W. Baird reaffirmed a “neutral” rating and set a $14.00 price objective (down from $28.00) on shares of Oscar Health in a research note on Friday, July 25th. Raymond James Financial cut Oscar Health from an “outperform” rating to a “market perform” rating in a research note on Tuesday, June 24th. UBS Group reiterated a “sell” rating and issued a $11.00 price objective (down from $15.00) on shares of Oscar Health in a research report on Tuesday, July 15th. Wall Street Zen cut shares of Oscar Health from a “hold” rating to a “sell” rating in a research note on Saturday, August 9th. Finally, Piper Sandler reduced their target price on shares of Oscar Health from $14.00 to $13.00 and set a “neutral” rating for the company in a research note on Thursday, August 14th. Four research analysts have rated the stock with a Hold rating and five have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Oscar Health has an average rating of “Strong Sell” and an average price target of $12.07.

Oscar Health Stock Performance

Shares of OSCR opened at $15.4140 on Friday. The company has a quick ratio of 0.86, a current ratio of 0.86 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 52-week low of $11.20 and a 52-week high of $23.79. The company has a 50-day simple moving average of $16.06 and a 200-day simple moving average of $14.79. The company has a market capitalization of $3.99 billion, a PE ratio of -19.03 and a beta of 1.86.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Wednesday, August 6th. The company reported ($0.89) EPS for the quarter, topping analysts’ consensus estimates of ($0.90) by $0.01. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. The firm had revenue of $2.86 billion for the quarter, compared to the consensus estimate of $2.88 billion. During the same quarter in the previous year, the firm earned $0.20 earnings per share. The firm’s revenue was up 29.0% on a year-over-year basis. Equities research analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.